Literature DB >> 582323

Species difference and characterization of intestinal esterase on the hydrolizing activity of ester-type drugs.

M Inoue, M Morikawa, M Tsuboi, M Sugiura.   

Abstract

The ability of the esterase from intestine was studied for hydrolysis of ester-type drugs during absorption. The intestinal esterase is present in the absorption sites in the intestine and hydrolyzes to a large extent during the absorption. In a study of the dietary effect on intestinal esterase, the esterase activity increased in rats fed a high-fat diet, decreased in those fasted or fed a fat-free diet, whereas the esterase activity in the rat treated with phenobarbital showed no marked change. Thus the esterase from intestinal mucosa appears to be characteristically quite different from hepatic esterase. The esterase from human intestine was characterized and compared with esterase from rats, mice, rabbits, guinea pigs and dogs. There was a difference in the substrate specificity of the esterase and there were significant species differences in the electrophoretic behavior of the enzyme among the species tested. These results indicate that intestinal esterase from humans differs characteristically from esterases in experimental animals.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 582323     DOI: 10.1254/jjp.29.9

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  10 in total

1.  Absorption and metabolism of procaine by the rat small intestine.

Authors:  J Rummel; H P Büch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

2.  Stability of alkoxycarbonylamidine prodrugs.

Authors:  Z Shahrokh; E Lee; A G Olivero; R A Matamoros; K D Robarge; A Lee; K J Weise; B K Blackburn; M F Powell
Journal:  Pharm Res       Date:  1998-03       Impact factor: 4.200

3.  The pharmacokinetics of aspirin in rats and the effect of buffer.

Authors:  C J Fu; S Melethil; W D Mason
Journal:  J Pharmacokinet Biopharm       Date:  1991-04

4.  Esterase-sensitive cyclic prodrugs of peptides: evaluation of an acyloxyalkoxy promoiety in a model hexapeptide.

Authors:  G M Pauletti; S Gangwar; F W Okumu; T J Siahaan; V J Stella; R T Borchardt
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

5.  A comparison of oral and rectal absorption of L-dopa esters in rats and mice.

Authors:  J A Fix; J Alexander; M Cortese; K Engle; P Leppert; A J Repta
Journal:  Pharm Res       Date:  1990-04       Impact factor: 4.200

6.  Short-chain alkyl esters of L-dopa as prodrugs for rectal absorption.

Authors:  J A Fix; J Alexander; M Cortese; K Engle; P Leppert; A J Repta
Journal:  Pharm Res       Date:  1989-06       Impact factor: 4.200

7.  Interspecies Differences in the Metabolism of a Multiester Prodrug by Carboxylesterases.

Authors:  Jing Fu; Erik Pacyniak; Marina G D Leed; Matthew P Sadgrove; Lesley Marson; Michael Jay
Journal:  J Pharm Sci       Date:  2016-01-12       Impact factor: 3.534

8.  Species dependent esterase activities for hydrolysis of an anti-HIV prodrug glycovir and bioavailability of active SC-48334.

Authors:  C S Cook; P J Karabatsos; G L Schoenhard; A Karim
Journal:  Pharm Res       Date:  1995-08       Impact factor: 4.200

9.  Conjugation of metronidazole with dextran: a potential pharmaceutical strategy to control colonic distribution of the anti-amebic drug susceptible to metabolism by colonic microbes.

Authors:  Wooseong Kim; Yejin Yang; Dohoon Kim; Seongkeun Jeong; Jin-Wook Yoo; Jeong-Hyun Yoon; Yunjin Jung
Journal:  Drug Des Devel Ther       Date:  2017-02-14       Impact factor: 4.162

Review 10.  Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs.

Authors:  Masakiyo Hosokawa
Journal:  Molecules       Date:  2008-02-18       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.